Rheumatoid Arthritis Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 75+ Leading Players Wheeling the Therapeutics Landscape The rheumatoid arthritis ...
The ceasefire in the Iran war abruptly faced its most perilous moment Monday after the United States began trying to open the ...
NImmune Biopharma ("NImmune"), a private, late-stage precision inflammation and immunology ("I&I") biopharmaceutical company, presented two studies at Digestive Disease Week (DDW), which together ...
SetPoint Medical, a medical technology company dedicated to improving care for people living with chronic autoimmune diseases ...
Announced positive topline induction data from Part A of the Phase 2 SKYLINE trial of SPY001, demonstrating best-in-class efficacy potential and ...
Stories by SWNS on MSN
Smoke visible for miles amid fire involving 200 tonnes of commercial waste
Firefighters are continuing to tackle a major blaze involving around 200 tonnes of commercial waste at an industrial site on ...
Three years after AbbVie stood at the edge of a major patent cliff with the loss of exclusivity for immunology ...
SetPoint Medical initiates enrolment in pilot study evaluating neuroimmune modulation for multiple sclerosis: Valencia, California Monday, May 4, 2026, 18:00 Hrs [IST] SetPoint Me ...
If you’re a believer in congressional districts drawn to best represent constituents instead of for pure partisan advantage, ...
Former boxer David Haye is said to be "absolutely gung-ho" and "incandescent with rage" with I'm A Celebrity.
Bristol Myers (BMY) faces a patent cliff, but a robust pipeline and CAR-T optionality plus 4.3% yield could spark upside—see ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results